TheraRadar
← Back
Data updated: Jul 17, 2026

EKR THERAP

Biotech
Pharmaceuticals

EKR THERAP is a biotechnology company with 1 FDA-approved products.

1998
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Biologics

EKR THERAP's Key Drugs

EKR THERAP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

EKR THERAP's Recent FDA Approvals

New NDA/BLA approvals for EKR THERAP over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

EKR THERAP's Therapeutic Areas

Disease areas where EKR THERAP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

EKR THERAP Pipeline Snapshot

Active clinical trials for EKR THERAP across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling